Sunshine Biopharma Inc. (SBFM) stock

SBFMNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as SBFMW

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 12/3099% below fair value

$2.84+0.09 (+3.27%)

Close on Nov 12, 2026Market cap $790.42KP/E –Yield –

Sunshine Biopharma EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Sunshine Biopharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

Parsed from the XBRL in Sunshine Biopharma's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-200 reverse split on Aug 13, 2026
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing